Type 1 IFN maintains the survival of anergic CD4+ T cells.
Lombardi G, Dunne PJ, Scheel-Toellner D, Sanyal T, Pilling D, Taams LS, Life P, Lord JM, Salmon M, Akbar AN.
Lombardi G, et al. Among authors: salmon m.
J Immunol. 2000 Oct 1;165(7):3782-9. doi: 10.4049/jimmunol.165.7.3782.
J Immunol. 2000.
PMID: 11034383